Clinical trial
Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
NCT00400387 · University of Jena, Other · Completed
Key facts
| NCT number | NCT00400387 |
|---|---|
| Title | Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss |
| Official title | Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss |
| Lead sponsor | University of Jena, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Abortion, Habitual |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Fragmin P Forte (dalteparin sodium), Multivitamin supplement |
| Enrollment | 449 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Apr 1, 2013 |
| First posted | Nov 16, 2006 |
| Last update posted | Sep 17, 2014 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: